Cheminova issues profit warning
Cheminova has been hit by lower-than-expected sales of its major product, the herbicide, glyphosate. The company has not achieved its expected first-half results, it says. That is despite sales growth in non-glyphosate products. Its full-year sales expectations have fallen from DKK6,500 million ($1,257 million at the current rate) to DKK5,800 million ($1,122 million). The herbicide is expected to account for around a quarter of company revenues and a “somewhat lower share” of earnings this year. The earnings before interest and tax (EBIT) margin will be down from the previously expected 9% ( Agrow No 565, pp 5-6) to 6-7%.